Bone mineral density fall during aromatase inhibitor treatment may predict lower breast cancer recurrence

Documenti analoghi

• Nomograms for predicting recurrence of HER2‐positive breast cancer with different HR status based on ultrasound and clinicopathological characteristics
  di: Xudong Zhang, et al.
  Pubblicazione: (2024)
• Fear of cancer recurrence in breast cancer survivors carrying a BRCA1/2 mutation: A qualitative study
  di: Josée Savard, et al.
  Pubblicazione: (2024)
• Mitochondrial dynamics as a novel treatment strategy for triple‐negative breast cancer
  di: Yuechen Wang, et al.
  Pubblicazione: (2024)
• Targeting the cancer cells and cancer‐associated fibroblasts with next‐generation FGFR inhibitors in prostate cancer co‐culture models
  di: Syeda Afshan, et al.
  Pubblicazione: (2024)
• Real‐world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancer
  di: Jasmine S. Sukumar, et al.
  Pubblicazione: (2024)